WBR0660

Revision as of 01:44, 16 September 2014 by Sergekorjian (talk | contribs)
Jump to navigation Jump to search
 
Author [[PageAuthor::Serge Korjian M.D. (Reviewed by Serge Korjian)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Biostatistics/Epidemiology
Sub Category SubCategory::Gastrointestinal
Prompt [[Prompt::A new vaccine is being developed for the prevention of Hepatitis E. In a phase 2 clinical trial, 100 individuals are randomized to receive either the vaccine or a placebo. Out of the 50 patients that received the vaccine 1 went on to develop Hepatitis E in the 6 month follow up after the vaccination. In the placebo group 7 out of 50 patients developed Hepatitis. What is the number needed to treat for this newly developed vaccine according to the results of this trial?]]
Answer A AnswerA::0.14
Answer A Explanation AnswerAExp::0.14 is not the number needed to treat
Answer B AnswerB::7.14
Answer B Explanation AnswerBExp::7.14 is not the number needed to treat
Answer C AnswerC::8.33
Answer C Explanation AnswerCExp::The number needed to treat in this trial is 8.33
Answer D AnswerD::300
Answer D Explanation AnswerDExp::300 is not the number needed to treat
Answer E AnswerE::Data insufficient to calculate
Answer E Explanation AnswerEExp::Given the equation below, all variables are available to calculate the number needed to treat.
Right Answer RightAnswer::C
Explanation [[Explanation::The number needed to treat refers to the number of patients required to receive a certain treatment for 1 patient to benefit from it. It is usually the inverse of the absolute risk reduction(ARR). The ARR can be calculated as follows:


Educational Objective: The number needed to treat is calculated by finding the inverse of the absolute risk reduction (1/ARR)
References: ]]

Approved Approved::Yes
Keyword WBRKeyword::Number needed to treat, WBRKeyword::Absolute risk reduction
Linked Question Linked::
Order in Linked Questions LinkedOrder::